{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T01:39:19Z","timestamp":1788485959417,"version":"build-2803163510"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T00:00:00Z","timestamp":1709683200000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"The IMPACT Consortium is a Cancer Moonshot Research Initiative"},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UM1CA233080"],"award-info":[{"award-number":["UM1CA233080"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Baptist Health System"},{"DOI":"10.13039\/100007886","name":"Dana-Farber Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007886","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001170","name":"Dartmouth Hitchcock Medical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001170","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Lifespan Health System"},{"DOI":"10.13039\/100009455","name":"West Virginia University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009455","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Optimal methods for deploying electronic patient-reported outcomes to manage symptoms in routine oncologic practice remain uncertain. The electronic symptom management (eSyM) program asks chemotherapy and surgery patients to self-report 12 common symptoms regularly. Feedback from nurses and patients led to changing the recall period from the past 7\u2009days to the past 24\u2009hours.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Using questionnaires submitted during the 16 weeks surrounding the recall period change, we assessed the likelihood of reporting severe or moderate and severe symptoms across 12 common symptoms and separately for the 5 most prevalent symptoms. Interrupted time-series analyses modeled the effects of the change using generalized linear mixed-effects models. Surgery and chemotherapy cohorts were analyzed separately. Study-wide effects were estimated using a meta-analysis method.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In total, 1692 patients from 6 institutions submitted 7823 eSyM assessments during the 16 weeks surrounding the recall period change. Shortening the recall period was associated with lower odds of severe symptom reporting in the surgery cohort (odds ratio\u2009=\u20090.65, 95% confidence interval\u2009=\u20090.46 to 0.93; P\u2009=\u2009.02) and lower odds of moderate and severe symptom reporting in the chemotherapy cohort (odds ratio\u2009=\u20090.83, 95% confidence interval\u2009=\u20090.71 to 0.97; P\u2009=\u2009.02). Among the most prevalent symptoms, 24-hour recall was associated with a lower rate of reporting postoperative constipation but no differences in reporting rates for other symptoms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>A shorter recall period was associated with a reduction in the proportion of patients reporting moderate-severe symptoms. The optimal recall period may vary depending on whether electronic patient-reported outcomes are collected for active symptom management, as a clinical trial endpoint, or another purpose.<\/jats:p>\n                    <jats:p>ClinicalTrials.gov ID NCT03850912.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jnci\/djae049","type":"journal-article","created":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T18:03:44Z","timestamp":1709575424000},"page":"1137-1144","source":"Crossref","is-referenced-by-count":11,"title":["Effects of a change in recall period on reporting severe symptoms: an analysis of a pragmatic multisite trial"],"prefix":"10.1093","volume":"116","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8584-7045","authenticated-orcid":false,"given":"Roshan","family":"Paudel","sequence":"first","affiliation":[{"name":"Dana-Farber Cancer Institute , Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea C","family":"Enzinger","sequence":"additional","affiliation":[{"name":"Dana-Farber Cancer Institute , Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Uno","sequence":"additional","affiliation":[{"name":"Dana-Farber Cancer Institute , Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Cronin","sequence":"additional","affiliation":[{"name":"Dana-Farber Cancer Institute , Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8594-6086","authenticated-orcid":false,"given":"Sandra L","family":"Wong","sequence":"additional","affiliation":[{"name":"Dartmouth Hitchcock Medical Center , Lebanon, NH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Don S","family":"Dizon","sequence":"additional","affiliation":[{"name":"Lifespan Cancer Institute and Brown University , Providence, RI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Hazard Jenkins","sequence":"additional","affiliation":[{"name":"West Virginia University Cancer Center , Morgantown, WV, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Bian","sequence":"additional","affiliation":[{"name":"Maine Medical Center , Portland, ME, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond U","family":"Osarogiagbon","sequence":"additional","affiliation":[{"name":"Baptist Medical Center , Memphis, TN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxanne E","family":"Jensen","sequence":"additional","affiliation":[{"name":"National Cancer Institute , Rockville, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra A","family":"Mitchell","sequence":"additional","affiliation":[{"name":"National Cancer Institute , Rockville, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Schrag","sequence":"additional","affiliation":[{"name":"Memorial Sloan Kettering Cancer Center , New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J","family":"Hassett","sequence":"additional","affiliation":[{"name":"Dana-Farber Cancer Institute , Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,3,5]]},"reference":[{"issue":"7","key":"2024070500015856900_djae049-B1","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1200\/JCO.20.02015","article-title":"Phase III Randomized Controlled Trial of eRAPID: ehealth intervention during chemotherapy","volume":"39","author":"Absolom","year":"2021","journal-title":"J Clin Oncol"},{"issue":"6","key":"2024070500015856900_djae049-B2","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1200\/JCO.2015.63.0830","article-title":"Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial","volume":"34","author":"Basch","year":"2016","journal-title":"J Clin Oncol"},{"issue":"8301","key":"2024070500015856900_djae049-B3","doi-asserted-by":"crossref","first-page":"n1647","DOI":"10.1136\/bmj.n1647","article-title":"Real time remote symptom monitoring during chemotherapy for cancer: European multicentre randomised controlled trial (eSMART)","volume":"374","author":"Maguire","year":"2021","journal-title":"BMJ"},{"key":"2024070500015856900_djae049-B4","doi-asserted-by":"crossref","first-page":"e2100137","DOI":"10.1200\/CCI.21.00137","article-title":"eSyM: an electronic health record-integrated patient-reported outcomes-based cancer symptom management program used by six diverse health systems","volume":"6","author":"Hassett","year":"2022","journal-title":"J Clin Oncol Clin Cancer Inform"},{"key":"2024070500015856900_djae049-B5","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1200\/CCI.21.00063","article-title":"Implementation of electronic patient-reported outcomes for symptom monitoring in a large multisite community oncology practice: dancing the Texas two-step through a pandemic","volume":"5","author":"Patt","year":"2021","journal-title":"J Clin Oncol Clin Cancer Inform"},{"issue":"4","key":"2024070500015856900_djae049-B6","doi-asserted-by":"crossref","first-page":"e215","DOI":"10.1200\/JOP.2013.001067","article-title":"Review of electronic patient-reported outcomes systems used in cancer clinical care","volume":"10","author":"Jensen","year":"2014","journal-title":"J Oncol Pract"},{"issue":"8","key":"2024070500015856900_djae049-B7","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1001\/jamaoncol.2022.2927","article-title":"Electronic monitoring of patient-reported outcomes-ready for prime time?","volume":"8","author":"Velazquez","year":"2022","journal-title":"JAMA Oncol"},{"issue":"3","key":"2024070500015856900_djae049-B8","doi-asserted-by":"crossref","first-page":"e221090","DOI":"10.1001\/jamanetworkopen.2022.1090","article-title":"Learning from real-world implementation of daily home-based symptom monitoring in patients with cancer","volume":"5","author":"Rocque","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"3","key":"2024070500015856900_djae049-B9","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1177\/1740774517698645","article-title":"Evaluation of different recall periods for the US National Cancer Institute's PRO-CTCAE","volume":"14","author":"Mendoza","year":"2017","journal-title":"Clin Trials"},{"key":"2024070500015856900_djae049-B10","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1200\/EDBK_159514","article-title":"Patient-reported outcomes in cancer clinical trials: measuring symptomatic adverse events with the national cancer institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)","volume":"35","author":"Kluetz","year":"2016"},{"issue":"1","key":"2024070500015856900_djae049-B11","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.pain.2008.03.024","article-title":"The accuracy of pain and fatigue items across different reporting periods","volume":"139","author":"Broderick","year":"2008","journal-title":"Pain"},{"key":"2024070500015856900_djae049-B12","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2147\/PROM.S256567","article-title":"Clinician and patient reporting of symptomatic adverse events in cancer clinical trials: using CTCAE and PRO-CTCAE((R)) to provide two distinct and complementary perspectives","volume":"13","author":"Minasian","year":"2022","journal-title":"Patient Relat Outcome Meas"},{"issue":"31","key":"2024070500015856900_djae049-B13","doi-asserted-by":"publisher","first-page":"JCO2018788620","DOI":"10.1200\/JClinOncol.2018.78.8620:JCO2018788620","article-title":"Feasibility of implementing the patient-reported outcomes version of the common terminology criteria for adverse events in a multicenter trial: NCCTG N1048","volume":"36","author":"Basch","year":"2018","journal-title":"J Clin Oncol"},{"issue":"9","key":"2024070500015856900_djae049-B14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jnci\/dju244","article-title":"Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)","volume":"106","author":"Basch","year":"2014","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"2024070500015856900_djae049-B15","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.jpainsymman.2014.06.011","article-title":"Comparison of seven-day and repeated 24-hour recall of symptoms in the first 100 days after hematopoietic cell transplantation","volume":"49","author":"Wood","year":"2015","journal-title":"J Pain Symptom Manage"},{"issue":"7","key":"2024070500015856900_djae049-B16","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1007\/s11136-023-03374-5","article-title":"Reliability and validity of PRO-CTCAE(R) daily reporting with a 24-hour recall period","volume":"32","author":"Lee","year":"2023","journal-title":"Qual Life Res"},{"key":"2024070500015856900_djae049-B17","doi-asserted-by":"publisher","DOI":"10.1093\/jncics\/pkad073","volume-title":"JNCI Cancer Spect.","author":"Smith","year":"2023"},{"issue":"1","key":"2024070500015856900_djae049-B18","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1186\/s13063-022-06435-1","article-title":"Implementation of patient-reported outcomes for symptom management in oncology practice through the SIMPRO research consortium: a protocol for a pragmatic type II hybrid effectiveness-implementation multi-center cluster-randomized stepped wedge trial","volume":"23","author":"Hassett","year":"2022","journal-title":"Trials"},{"issue":"1","key":"2024070500015856900_djae049-B19","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1177\/1740774520975120","article-title":"Composite grading algorithm for the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)","volume":"18","author":"Basch","year":"2021","journal-title":"Clin Trials"},{"issue":"suppl 28","key":"2024070500015856900_djae049-B20","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1200\/JCO.2022.40.28_suppl.242","article-title":"Severe symptom reporting in medical oncology patients at community cancer centers assessed through eSyM","volume":"40","author":"Bian","year":"2022","journal-title":"J Clin Oncol"},{"key":"2024070500015856900_djae049-B21","doi-asserted-by":"publisher","author":"Wong","year":"2022","DOI":"10.1200\/JCO.2022.40.28_suppl.243"},{"key":"2024070500015856900_djae049-B22","volume-title":"Statistical Meta-Analysis with Applications","author":"Sinha","year":"2011"},{"issue":"4","key":"2024070500015856900_djae049-B23","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1185\/03007990902774765","article-title":"Optimal recall periods for patient-reported outcomes: challenges and potential solutions","volume":"25","author":"Stull","year":"2009","journal-title":"Curr Med Res Opin"},{"issue":"3","key":"2024070500015856900_djae049-B24","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s11136-019-02344-0","article-title":"Does recall period matter? Comparing PROMIS((R)) physical function with no recall, 24-hr recall, and 7-day recall","volume":"29","author":"Condon","year":"2020","journal-title":"Qual Life Res"},{"issue":"7","key":"2024070500015856900_djae049-B25","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1007\/s11136-012-0323-3","article-title":"Psychometric characteristics of daily diaries for the Patient-Reported Outcomes Measurement Information System (PROMIS(R)): a preliminary investigation","volume":"22","author":"Schneider","year":"2013","journal-title":"Qual Life Res"},{"key":"2024070500015856900_djae049-B26","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1200\/CCI.20.00081","article-title":"Clinical utility and user perceptions of a digital system for electronic patient-reported symptom monitoring during routine cancer care: findings from the PRO-TECT trial","volume":"4","author":"Basch","year":"2020","journal-title":"J Clin Oncol Clin Cancer Inform"},{"issue":"12","key":"2024070500015856900_djae049-B27","doi-asserted-by":"crossref","first-page":"e1943","DOI":"10.1200\/OP.22.00360","article-title":"Adaptation of remote symptom monitoring using electronic patient-reported outcomes for implementation in real-world settings","volume":"18","author":"Rocque","year":"2022","journal-title":"J Clin Oncol Oncol Pract"},{"issue":"3","key":"2024070500015856900_djae049-B28","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1177\/17407745221093935","article-title":"Timing is everything: the importance of patient-reported outcome assessment frequency when characterizing symptomatic adverse events","volume":"19","author":"King-Kallimanis","year":"2022","journal-title":"Clin Trials"},{"key":"2024070500015856900_djae049-B29","doi-asserted-by":"crossref","first-page":"723427","DOI":"10.3389\/fphar.2021.723427","article-title":"Pharmacoepidemiology research-real-world evidence for decision making","volume":"12","author":"Berard","year":"2021","journal-title":"Front Pharmacol"},{"issue":"3","key":"2024070500015856900_djae049-B30","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s43441-020-00252-x","article-title":"Demonstrating that real world evidence is fit-for-purpose to support labeling: parallels to patient reported outcomes in the pursuit of labeling claims","volume":"55","author":"Girman","year":"2021","journal-title":"Ther Innov Regul Sci"},{"issue":"14","key":"2024070500015856900_djae049-B31","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1200\/JClinOncol.22.02874:JCO2202874","article-title":"What is the optimal way to use geriatric assessment and patient-reported outcomes in older patients with advanced cancer?","volume":"41","author":"Kaneko","year":"2023","journal-title":"J Clin Oncol"},{"issue":"8","key":"2024070500015856900_djae049-B32","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1017\/ice.2019.114","article-title":"Analysis of multisite intervention studies using generalized linear mixed models","volume":"40","author":"White","year":"2019","journal-title":"Infect Control Hosp Epidemiol"}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jnci\/advance-article-pdf\/doi\/10.1093\/jnci\/djae049\/57146756\/djae049.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnci\/article-pdf\/116\/7\/1137\/58443110\/djae049.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnci\/article-pdf\/116\/7\/1137\/58443110\/djae049.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T20:04:27Z","timestamp":1720123467000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article\/116\/7\/1137\/7623084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,5]]},"references-count":32,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,3,5]]},"published-print":{"date-parts":[[2024,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/djae049","relation":{},"ISSN":["0027-8874","1460-2105"],"issn-type":[{"value":"0027-8874","type":"print"},{"value":"1460-2105","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,7]]},"published":{"date-parts":[[2024,3,5]]}}}